Researchers in Calgary have developed a promising immunotherapy for solid tumors, with one approach showing potential against aggressive brain tumors. The treatment, which may involve a CAR T-cell therapy, has reportedly reduced rare cancerous tumors in some cases. The development appears to be part of a broader effort to advance cancer care, possibly including collaborations and funding initiatives to target various types of cancer, including pancreatic cancer.